Bio-Rad Laboratories | BIO - Fremdkapital

Aktienkurs
279.72
Täglich Wechseln
4.57 1.66%
Monatlich
0.35%
Jährlich
16.58%
Q2 Prognose
281.68




Fremdkapital Veränderung Datum
Abbott USD 29.64B 19.74B 2026-03
Agilent USD 3.05B 0 2025-12
Becton, Dickinson and Co. USD 16.92B 705M 2025-12
Bio Techne USD 260M 40M 2025-12
Bio-Rad Laboratories USD 1.2B 300K 2025-12
Bruker USD 1.85B 131.7M 2025-12
Charles River Laboratories USD 2.14B 49.09M 2025-12
Danaher USD 17.56B 855M 2026-03
General Electric Aerospace USD 18.17B 634M 2026-03
Illumina USD 1.49B 496M 2025-12
IQVIA Holdings USD 13.88B 1.09B 2025-12
Laboratory Of America USD 5.15B 800K 2025-12
Merck USD 46.75B 6.78B 2025-12
Mettler Toledo International USD 2.09B 58.01M 2025-12
Myriad Genetics USD 119.9M 400K 2025-12
OraSure Technologies USD 100K 17K 2025-12
Pacific Biosciences Of California USD 645.38M 223K 2025-12
Quest Diagnostics USD 5.16B 12M 2026-03
Repligen USD 542.21M 4.29M 2025-12
Revvity USD 2.63B 543K 2025-12
Roche Holding CHF 27.43B 966M 2025-12
Siemens EUR 42.84B 2.01B 2025-12
Standard Biotools USD 299K 0 2025-12
Thermo Fisher Scientific USD 40.07B 4.22B 2026-03
Tosoh JPY 74.39B 22.26B 2025-12
Waters USD 1.41B 460.24M 2025-12